519 related articles for article (PubMed ID: 25448242)
1. Toward a translational approach to targeting the endocannabinoid system in posttraumatic stress disorder: a critical review of preclinical research.
Papini S; Sullivan GM; Hien DA; Shvil E; Neria Y
Biol Psychol; 2015 Jan; 104():8-18. PubMed ID: 25448242
[TBL] [Abstract][Full Text] [Related]
2. Tempering aversive/traumatic memories with cannabinoids: a review of evidence from animal and human studies.
Lisboa SF; Vila-Verde C; Rosa J; Uliana DL; Stern CAJ; Bertoglio LJ; Resstel LB; Guimaraes FS
Psychopharmacology (Berl); 2019 Jan; 236(1):201-226. PubMed ID: 30604182
[TBL] [Abstract][Full Text] [Related]
3. The endocannabinoid system in the amygdala and modulation of fear.
Gunduz-Cinar O
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 105():110116. PubMed ID: 32976951
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the endocannabinoid system by sex hormones: Implications for posttraumatic stress disorder.
Ney LJ; Matthews A; Bruno R; Felmingham KL
Neurosci Biobehav Rev; 2018 Nov; 94():302-320. PubMed ID: 30017748
[TBL] [Abstract][Full Text] [Related]
5. Targeting the endocannabinoid system to treat anxiety-related disorders.
Korem N; Zer-Aviv TM; Ganon-Elazar E; Abush H; Akirav I
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):193-202. PubMed ID: 26426887
[TBL] [Abstract][Full Text] [Related]
6. Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder.
Hill MN; Campolongo P; Yehuda R; Patel S
Neuropsychopharmacology; 2018 Jan; 43(1):80-102. PubMed ID: 28745306
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention.
Mizrachi Zer-Aviv T; Segev A; Akirav I
Behav Pharmacol; 2016 Oct; 27(7):561-9. PubMed ID: 27551883
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacological intervention of conditioned fear and its extinction].
Huang R; Li Z; Chen H; Huang Y; Ding L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 37(9):968-72. PubMed ID: 23000774
[TBL] [Abstract][Full Text] [Related]
9. Effects of endocannabinoid and endovanilloid systems on aversive memory extinction.
Laricchiuta D; Centonze D; Petrosini L
Behav Brain Res; 2013 Nov; 256():101-7. PubMed ID: 23948212
[TBL] [Abstract][Full Text] [Related]
10. Role of beta-catenin and endocannabinoids in the nucleus accumbens in extinction in rats exposed to shock and reminders.
Korem N; Lange R; Hillard CJ; Akirav I
Neuroscience; 2017 Aug; 357():285-294. PubMed ID: 28624572
[TBL] [Abstract][Full Text] [Related]
11. Facilitating Fear-Based Memory Extinction With Dexamethasone: A Randomized Controlled Trial in Male Veterans With Combat-Related PTSD.
Surís A; Holliday R; Adinoff B; Holder N; North CS
Psychiatry; 2017; 80(4):399-410. PubMed ID: 29466111
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of elevated anandamide on stress and fear-related behaviors: translational evidence from humans and mice.
Mayo LM; Asratian A; Lindé J; Holm L; Nätt D; Augier G; Stensson N; Vecchiarelli HA; Balsevich G; Aukema RJ; Ghafouri B; Spagnolo PA; Lee FS; Hill MN; Heilig M
Mol Psychiatry; 2020 May; 25(5):993-1005. PubMed ID: 30120421
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid modulation of corticolimbic activation during extinction learning and fear renewal in adults with posttraumatic stress disorder.
Zabik NL; Rabinak CA; Peters CA; Iadipaolo A
Neurobiol Learn Mem; 2023 May; 201():107758. PubMed ID: 37088409
[TBL] [Abstract][Full Text] [Related]
14. Regulation of fear extinction by long-term depression: The roles of endocannabinoids and brain derived neurotrophic factor.
Bennett MR; Arnold J; Hatton SN; Lagopoulos J
Behav Brain Res; 2017 Feb; 319():148-164. PubMed ID: 27867101
[TBL] [Abstract][Full Text] [Related]
15. The endocannabinoid system and Post Traumatic Stress Disorder (PTSD): From preclinical findings to innovative therapeutic approaches in clinical settings.
Berardi A; Schelling G; Campolongo P
Pharmacol Res; 2016 Sep; 111():668-678. PubMed ID: 27456243
[TBL] [Abstract][Full Text] [Related]
16. Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review.
Steenkamp MM; Blessing EM; Galatzer-Levy IR; Hollahan LC; Anderson WT
Depress Anxiety; 2017 Mar; 34(3):207-216. PubMed ID: 28245077
[TBL] [Abstract][Full Text] [Related]
17. A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: potential extinction enhancers.
de Bitencourt RM; Pamplona FA; Takahashi RN
Neuropharmacology; 2013 Jan; 64():389-95. PubMed ID: 22687521
[TBL] [Abstract][Full Text] [Related]
18. Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review.
Orsolini L; Chiappini S; Volpe U; Berardis D; Latini R; Papanti GD; Corkery AJM
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31450833
[TBL] [Abstract][Full Text] [Related]
19. Differential roles of the infralimbic and prelimbic areas of the prefrontal cortex in reconsolidation of a traumatic memory.
Levin N; Kritman M; Maroun M; Akirav I
Eur Neuropsychopharmacol; 2017 Sep; 27(9):900-912. PubMed ID: 28647452
[TBL] [Abstract][Full Text] [Related]
20. The role of endocannabinoids in consolidation, retrieval, reconsolidation, and extinction of fear memory.
Mizuno I; Matsuda S
Pharmacol Rep; 2021 Aug; 73(4):984-1003. PubMed ID: 33954935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
